|Articles|December 15, 2002
- BioPharm International-12-15-2002
- Volume 15
- Issue 1
Guest Editorial: EPO Saga to Augur Regulatory Change?
Author(s)Gordon Kelley
by Gordon Kelley, BioPharm International magazine
Advertisement
Articles in this issue
almost 23 years ago
BioPharm International Five-Year Article Indexalmost 23 years ago
Evaluation of Extractables from Product-Contact Surfacesalmost 23 years ago
Monitoring and Controlling Biocatalytic ProcessesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
